Skip to main content

Find Clinical Trials

Home
Conditions
Burkitt-Like Lymphoma With 11q Aberration

Clinical trial condition

Burkitt-Like Lymphoma With 11q Aberration

Explore clinical trials studying Burkitt-Like Lymphoma With 11q Aberration. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Burkitt-Like Lymphoma With 11q Aberration trial results

Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

NCT01371630

Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details